Signs and Symptoms, Respiratory
Welcome,         Profile    Billing    Logout  
 32 Companies   48 Products   48 Products   64 Mechanisms of Action   1 Trial   1048 News 


«12...345678910111213...2021»
  • ||||||||||  Trial initiation date, HEOR, Cost effectiveness:  Home Nasal Pressure for Sleep Apnea Management in Primary Case (clinicaltrials.gov) -  Jun 11, 2015   
    P2,  N=280, Not yet recruiting, 
    Initiation date: Mar 2014 --> Mar 2016
  • ||||||||||  Enrollment change:  The Use of Heliox in Obstructive Sleep Apnea Syndrome (clinicaltrials.gov) -  Jun 11, 2015   
    P2,  N=32, Completed, 
    Initiation date: Mar 2014 --> Mar 2016 N=50 --> 32
  • ||||||||||  Biomarker, Enrollment change, Trial termination, Trial primary completion date:  The Triple A Initiative Study ("Aktionsbündnis Akute Atemnot") (clinicaltrials.gov) -  Jun 11, 2015   
    P=N/A,  N=67, Terminated, 
    N=50 --> 32 N=460 --> 67 | Recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Apr 2015; recruitment numbers lower than expected
  • ||||||||||  Trial completion:  Cough Monitoring Study (clinicaltrials.gov) -  Jun 8, 2015   
    P=N/A,  N=33, Completed, 
    Recruiting --> Completed | N=30 --> 20 | Trial primary completion date: Dec 2013 --> Mar 2015 Active, not recruiting --> Completed
  • ||||||||||  ticagrelor / Generic mfg.
    Enrollment open, Trial primary completion date:  TROCADERO: Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor (clinicaltrials.gov) -  Jun 6, 2015   
    P2,  N=500, Recruiting, 
    Active, not recruiting --> Completed Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2015 --> Dec 2016
  • ||||||||||  Enrollment change, Trial withdrawal, Trial primary completion date:  OSAVTE: Obstructive Sleep Apnea and Venous Thromboembolism (clinicaltrials.gov) -  May 28, 2015   
    P=N/A,  N=0, Withdrawn, 
    Recruiting --> Active, not recruiting N=185 --> 0 | Enrolling by invitation --> Withdrawn | Trial primary completion date: Dec 2010 --> May 2015
  • ||||||||||  Enrollment closed, Trial primary completion date:  Oxygen Supplementation Study in Obstructive Sleep Apnea (OSA) Patients (clinicaltrials.gov) -  May 28, 2015   
    P=N/A,  N=156, Active, not recruiting, 
    N=185 --> 0 | Enrolling by invitation --> Withdrawn | Trial primary completion date: Dec 2010 --> May 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Dec 2015
  • ||||||||||  Enrollment open, Trial initiation date:  SleepICU: Efficacy of Closed-loop Ventilation to Reduced Sleep Disorders (clinicaltrials.gov) -  May 27, 2015   
    P=N/A,  N=20, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Dec 2015 Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Oct 2014
  • ||||||||||  Trial completion, Trial primary completion date:  Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial. (clinicaltrials.gov) -  May 27, 2015   
    P2,  N=19, Completed, 
    Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Oct 2014 Recruiting --> Completed | Trial primary completion date: Jan 2014 --> Apr 2015
  • ||||||||||  furosemide / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date:  Aerosol Inhalation Treatment for Dyspnea (clinicaltrials.gov) -  May 6, 2015   
    P1/2,  N=15, Completed, 
    Recruiting --> Completed Recruiting --> Completed | N=32 --> 15 | Trial primary completion date: Sep 2016 --> Apr 2015
  • ||||||||||  Enrollment open, Trial initiation date:  Airway Muscle Training for Obstructive Sleep Apnea (clinicaltrials.gov) -  Apr 22, 2015   
    P=N/A,  N=60, Recruiting, 
    Initiation date: Apr 2015 --> Apr 2016 | Trial primary completion date: Nov 2015 --> Nov 2016 Not yet recruiting --> Recruiting | Initiation date: Oct 2014 --> Apr 2015
  • ||||||||||  chlorthalidone / Generic mfg., amiloride hydrochloride / Generic mfg.
    Enrollment open, Trial initiation date, Trial primary completion date:  Effect of Antihypertensive Agents Over Sleep Apnea (clinicaltrials.gov) -  Apr 17, 2015   
    P3,  N=58, Recruiting, 
    Recruiting --> Terminated Not yet recruiting --> Recruiting | Initiation date: Aug 2013 --> Dec 2014 | Trial primary completion date: Sep 2014 --> Dec 2015
  • ||||||||||  Biomarker, Trial primary completion date:  The Triple A Initiative Study ("Aktionsbündnis Akute Atemnot") (clinicaltrials.gov) -  Apr 15, 2015   
    P=N/A,  N=460, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Jun 2014 --> Dec 2015
  • ||||||||||  Trial primary completion date:  Reproductive Aging and Obstructive Sleep Apnea (clinicaltrials.gov) -  Apr 15, 2015   
    P=N/A,  N=16, Recruiting, 
    Trial primary completion date: Oct 2013 --> Dec 2015 Trial primary completion date: May 2015 --> Nov 2016
  • ||||||||||  GSK2339345 / GSK
    Enrollment change, Reflex:  GSK2339345 Hypertussive Challenge Study (clinicaltrials.gov) -  Apr 15, 2015   
    P2,  N=16, Completed, 
    Trial primary completion date: May 2015 --> Nov 2016 N=11 --> 16
  • ||||||||||  Enrollment open, Trial primary completion date:  Efficacy and Physiology of Nasal High Flow Therapy (clinicaltrials.gov) -  Mar 24, 2015   
    P=N/A,  N=40, Recruiting, 
    Active, not recruiting --> Completed Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2015 --> Jun 2016
  • ||||||||||  Trial completion, Trial primary completion date:  Study of Nasal Airflow Pressure Optimization to Resolve Excessive Snoring (clinicaltrials.gov) -  Mar 24, 2015   
    P=N/A,  N=26, Completed, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2015 --> Jun 2016 Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jul 2014
  • ||||||||||  Trial completion, Phase classification:  Buspirone in Reducing Shortness of Breath in Patients With Cancer (clinicaltrials.gov) -  Mar 20, 2015   
    P2/3,  N=432, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed | Phase classification: PN/A --> P2/3
  • ||||||||||  Trial completion, Enrollment change:  Mild Cognitive Impairment and Obstructive Sleep Apnea (clinicaltrials.gov) -  Mar 17, 2015   
    P3,  N=86, Completed, 
    Recruiting --> Active, not recruiting Recruiting --> Completed | N=110 --> 86
  • ||||||||||  Trial completion, Enrollment change:  AVSAS: Role of Obstructive Sleep Apnea in Stroke Appearance (clinicaltrials.gov) -  Mar 7, 2015   
    P=N/A,  N=289, Completed, 
    Trial primary completion date: Oct 2012 --> May 2011 Recruiting --> Completed | N=750 --> 289
  • ||||||||||  dexmedetomidine / Generic mfg.
    Clinical:  Sedative Effects in Obstructive Sleep Apnea (clinicaltrials.gov) -  Mar 5, 2015   
    P2/3,  N=0, Withdrawn, 
    Recruiting --> Completed | N=750 --> 289 N=20 --> 0 | Initiation date: Sep 2014 --> Mar 2015 | Not yet recruiting --> Withdrawn
  • ||||||||||  fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
    Enrollment change, Trial withdrawal:  Shortness Of Breath Questionnaire Validation Study (clinicaltrials.gov) -  Feb 23, 2015   
    P3,  N=0, Withdrawn, 
    Not yet recruiting --> Recruiting N=350 --> 0 | Terminated --> Withdrawn